Brain-derived neurotrophic factor gene (BDNF) variants and schizophrenia:: An association study

被引:91
作者
Jonsson, Erik G.
Edman-Ahlbom, Bodil
Sillen, Anna
Gunnar, Agneta
Kulle, Bettina
Frigessi, Amoldo
Vares, Maria
Ekholm, Birgit
Wode-Helgodt, Birgitta
Schumacher, Johannes
Cichon, Sven
Agartz, Ingrid
Sedvall, Goran C.
Hall, Hakan
Terenius, Lars
机构
[1] Karolinska Hosp & Inst, HUBIN Project, Dept Clin Neurosci, SE-17176 Stockholm, Sweden
[2] Inst Grp Basic Med Sci, Dept Biostat, Oslo, Norway
[3] Univ Bonn, Inst Human Genet, D-5300 Bonn, Germany
[4] Univ Bonn, Dept Genom, Life & Brain Ctr, D-5300 Bonn, Germany
[5] Psykiatrisk Inst, Oslo, Norway
关键词
brain-derived neurotrophic factor (BDNF); genetics; meta-analysis; schizophrenia;
D O I
10.1016/j.pnpbp.2006.02.008
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Polymorphisms in the brain-derived neurotrophic factor (BDNF) gene have been suggested to be associated with schizophrenia. In a replication attempt, Swedish patients with schizophrenia (n = 187) and control subjects (n = 275) were assessed for four BDNF gene polymorphisms. There were no significantly different allele, genotype or haplotype frequencies between cases or controls. Neither were there any differences when schizophrenic patients were sub-divided with regard to a number of different clinical variables, although a small group of psychotic patients with prominent affective features displayed higher frequencies of the less common alleles of the Val66Met and 11757 G/C polymorphisms compared to controls. The present Swedish results do not verify previous associations between putative functional BDNF gene polymorphisms and schizophrenia. However, when combined with previous studies meta-analyses indicated that the BDNF 270 T-allele and the Val66Met homozygous state were associated with the disorder. Thus, the BDNF gene may confer susceptibility to schizophrenia. Additional studies are warranted to shed further light on this possibility. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:924 / 933
页数:10
相关论文
共 89 条
[1]   Single-nucleotide polymorphism analysis by pyrosequencing [J].
Ahmadian, A ;
Gharizadeh, B ;
Gustafsson, AC ;
Sterky, F ;
Nyrén, P ;
Uhlén, M ;
Lundeberg, J .
ANALYTICAL BIOCHEMISTRY, 2000, 280 (01) :103-110
[2]  
American Psychiatric Association, 1995, DIAGN STAT MAN MENT
[3]   Lack of association between two polymorphisms of brain-derived neurotrophic factor and response to typical neuroleptics [J].
Anttila, S ;
Illi, A ;
Kampman, O ;
Mattila, KM ;
Lehtimäki, T ;
Leinonen, E .
JOURNAL OF NEURAL TRANSMISSION, 2005, 112 (07) :885-890
[4]   Schizophrenia, a neurodegenerative disorder with neurodevelopmental antecedents [J].
Ashe, PC ;
Berry, MD ;
Boulton, AA .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2001, 25 (04) :691-707
[5]   Haploview: analysis and visualization of LD and haplotype maps [J].
Barrett, JC ;
Fry, B ;
Maller, J ;
Daly, MJ .
BIOINFORMATICS, 2005, 21 (02) :263-265
[6]   The efficacy of 2 different dosages of methylphenidate in treating adults with attention-deficit hyperactivity disorder [J].
Bouffard, R ;
Hechtman, L ;
Minde, K ;
Iaboni-Kassab, F .
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2003, 48 (08) :546-554
[7]   Interactions between monoamines, glutamate, and GABA in schizophrenia: New evidence [J].
Carlsson, A ;
Waters, N ;
Holm-Waters, S ;
Tedroff, J ;
Nilsson, M ;
Carlsson, ML .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2001, 41 :237-260
[8]  
Cohen J., 1988, STAT POWER ANAL BEHA
[9]   NATURE OF THE GENETIC CONTRIBUTION TO PSYCHOTIC ILLNESS - A CONTINUUM VIEWPOINT [J].
CROW, TJ .
ACTA PSYCHIATRICA SCANDINAVICA, 1990, 81 (05) :401-408
[10]   Transcription factor AP-2β genotype, striatal dopamine D2 receptor density and cerebrospinal fluid monoamine metabolite concentrations in humans [J].
Damberg, M ;
Berggård, C ;
Farde, L ;
Sedvall, GC ;
Jönsson, EG .
JOURNAL OF NEURAL TRANSMISSION, 2004, 111 (04) :537-545